Fearon will play a pivotal role in enhancing the regulatory science consulting firm's capabilities.Read More
Tags : PMTA
The applications did not provide sufficient evidence to show comparative health risk data.Read More
The proposed rule is open for public comment until Sept. 6, 2023.Read More
Based on the latest status report, the FDA plans to have 55 percent covered by Sept. 30. Read More
As Altria sheds the burden of Juul, its leaders are hoping investors ‘Njoy’ the company’s new outlook.Read More
Protect the Public's Trust says the FDA makes "scientifically unfounded" claims about the vaping industry.Read More
Experts share their insights relating to tobacco harm reduction during the April 25 In Focus webinar.Read More
The head of the FDA’s Center for Tobacco Products sent mixed messages during a recent event.Read More
Chairman James Comer is conducting the probe following the Reagan-Udall Foundation's findings. Read More
Judges agree that the FDA changed the decision-making criteria after the PMTA submissions were made.Read More
